Being a Scientist in India
Popular Posts
-
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the...
-
Whether you’re a seasoned professional, in search of a new hobby, or a student looking for new material to help you study, watching online ...
-
No matter how much you know, there is always something new to learn about science. While your college courses may cover the basics, you ca...
-
Sc!deation new ideas in drug discovery, development & commercialization Crowdfunding for Technology Startups by Euan Ramsay on...
-
Clinical Trials Of Breakthrough Gene Therapy To Treat HIV Expected In 2012 Scientists at Calimmune, a stem cell company founded by...
-
Generating 'Green' Electricity: Waste Heat Converted to Electricity Using New Alloy ScienceDaily (June 27, 2011) — University of M...
-
http://www.youtube.com/watch?v=30KfPtHec4s
-
I was in Mumbai when I got a mail from BITS-PILANI that we have been selected among the top 30 teams of CONQUEST 2011 - AN INTERNATIONAL B P...
-
Bacterial Resistance to Antibiotics: The More They Resist, the More They Divide ScienceDaily (Ju...
-
The process of developing new drugs can be long and expensive. Optive Research Inc. aims to make the search faster and more efficient with...
Wednesday, August 17, 2011
Saturday, August 6, 2011
An Hour at the most desirable Institute of India.
I was in Mumbai when I got a mail from BITS-PILANI that we have been selected among the top 30 teams of CONQUEST 2011 - AN INTERNATIONAL B PLAN CONTEST. I was really very happy as it was my first international selection.Conquest is one of the most prestigious B Plan contest of India organized by CEL, BITS.It gives you an international platform to share your business idea to the best Entrepreneurs of country who further sharpen your idea and really want you to choose the rare path of entrepreneurship for which they went for.It was really great that we were selected out of 1800 participants who applied from 18 different countries.The mentoring sessions organized by Conquest team was really great as we were able to know certain aspects of the plan that we missed totally.To refine our idea to best level possible and improve chances to successfully implement the plan we wrote to the CENTER FOR INNOVATION , INCUBATION AND ENTREPRENEURSHIP , IIM-AHEMADABAD.Fortunately we got a positive response from Mr. Pranay Gupta the CEO of CIIE,IIM-A who had great record of supporting the most sensational startups of India.I reached IIM-A with my friend Kushal who actually came with the eureka moment.We reached the new campus of IIM-A on the right side of which is CIIE is located.I was great to talk Mr.Pranay Gupta.He showed great enthusiasm in our project and assured to help in all possible means.Then me and kushal just went around the campus of a Institute which gives the highest financial secutrity in your life.It was really great to feel the LOUIS KHAN PLAZA.You can easily feel the warmth of the love with which Louis Khan designed the institute.Only going there you can really know the vision of Dr.Vikram Sarabhai.Hope we will make out and will be part of the best stories of CIIE.
A good initiative by Indian Govt to curb Antibiotic Misuse.
Regulating Over-the-Counter Antibiotic Sales: What Will "Schedule HX" Mean for India?
2 Aug 2011
In the wake of the NDM-1 controversy, the Government of India created a committee to frame a new antibiotic policy for the country. One of the recommendations of this committee was to regulate the sale of antibiotics by introducing “Schedule H1” under the Drugs and Cosmetics rules, to “regulate sale of antibiotics exclusively” (Ministry of Health & Family Welfare 2011). The existing Schedule H contains 536 drugs, which cannot be legally dispensed without the prescription of a registered medical practitioner (RMP). The packaging of these drugs must include the warning “Schedule H drug - warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.” Schedule H1 was envisioned as a tool to enable strict regulation of the sale of third generation antibiotics, despite the fact that regulation of the other Schedule H drugs is rarely enforced.
The antibiotic policy written by this committee is currently under review by the Union Law Ministry, after which it will be reviewed by the Drugs Technical Advisory Board (Assary 2011). The proposal (for what is now called Schedule HX) contains two parts. Part A consists of 16 antibiotics that should only be sold in tertiary hospitals. These drugs will be color-coded to enable quick identification. These 16 drugs include Cefpirome, Colistin, Doripenem, Ertapenem, Imipenem, Linezolid, Meropenem, and Moxifloxacin (Assary 2011).
Part B contains 74 drugs that could only be sold at pharmacies to patients with two copies of a prescription from a RMP. These include Amoxicillin, Ampicillin, Cefaclor, Cefalexin, Cefdinir, Ciprofloxacin, Erythromycin, Gentamicin, Norfloxacin, Oxacillin, Pencillin, antibiotic eye drops, some drugs for tuberculosis, sleeping pills, paracetamol and cough syrups such as Benadryl (Assary 2011; Deshpande 2011; Times News Network 2011).
Some Ministry of Health officials and doctors have defended the new regulations, pointing out that only very specialized, expensive drugs will be limited to tertiary hospitals, and that it is important to restrict these antibiotics to stem the spread of antibiotic resistance (Deshpande 2011; Express News Service 2011). Indeed, in situations where diagnostic and antibiotic sensitivity tests are unavailable, it is unwise for patients to take expensive, strong drugs. These drugs should only be prescribed when it has been determined that the patient is resistant to milder, widely available antibiotics through diagnostic tests. If patients are wantonly prescribed newer antibiotics, such as those restricted to tertiary hospitals, this will lead to a decrease in their effectiveness when patients with resistant infections really need them.
However, several parts of this new regulation have caused widespread protest. The All India Organization of Chemists and Druggists (AIOCD) has pointed out that in many rural areas, RMPs are scarce or unavailable, making many drugs inaccessible to rural populations (Deshpande 2011). Others fear that new regulations will make life-saving drugs scarce, and lead to increased use of the black market (Indian Pharmacist Association and Pharmabiz 2011). To show their opposition, several pharmacists’ organizations staged a strike on August 1st (Express News Service 2011; Indian Pharmacist Association and Pharmabiz 2011; Times News Network 2011). However, many re-opened during the day due to the protests of customers and police (Express News Service 2011). After a meeting with the Health Minister, the strike was officially called off in Delhi and other locations, based on the feeling that there is still time to change the specifics of the new regulations before they are enacted (Ahuja 2011; Indo-Asian News Service 2011).
These controversial new regulations raise a number of interesting issues. Of course, pharmacists are only part of the picture. The new antibiotic policy contains measures targeting overprescribing of antibiotics as well, such as educational programs for physicians (Ministry of Health & Family Welfare 2011). Preventing doctors from primary and secondary level facilities from dispensing the newest antibiotics without the diagnostic tests to determine whether they are necessary could also go a long way towards preserving the effectiveness of new antibiotics, which would ideally only be used when absolutely necessary. However, these regulations may have been diluted by the inclusion of drugs other than antibiotics. I find it hard to believe that I will actually be unable to buy paracetamol (acetaminophen) and cough syrup once these new regulations are put in place. Just in case, I’m planning on stocking up.
------------------------------------
References:
Ahuja, S. (2011). Chemists to remain open on August 1. Hindustan Times. Gurgaon.
Assary, G. (2011). Losing battle against bacteria? Deccan Chronicle. Thiruvananthapuram.
Deshpande, D. (2011). Chemists super bugged by govt’s new policy. Pune Mirror. Pune.
Express News Service (2011). Chemists strike over new rules for drug sale, leave patients stranded. Indian Express. New Delhi.
Express News Service (2011). Chemists to down shutters on Aug 1 to protest antibiotics order. Indian Express.
Indian Pharmacist Association and Pharmabiz. (2011). "AICDF calls for pharmacy bandh in Delhi & Haryana against govt’s decision to include Schedule HX in D&C Rules." Retrieved July 29, 2011.
Indo-Asian News Service (2011). Chemists end strike after meeting Ghulam Nabi Azad. NDTV. New Delhi.
Ministry of Health & Family Welfare. (2011). "National Policy for Containment of Antimicrobial Resistance - India." from http://www.nicd.nic.in/ncdc_new/ab_policy.pdf.
Times News Network (2011). Druggists warn of stir over move to ban 90 OTC drugs. Times of India. Hyderabad.
The antibiotic policy written by this committee is currently under review by the Union Law Ministry, after which it will be reviewed by the Drugs Technical Advisory Board (Assary 2011). The proposal (for what is now called Schedule HX) contains two parts. Part A consists of 16 antibiotics that should only be sold in tertiary hospitals. These drugs will be color-coded to enable quick identification. These 16 drugs include Cefpirome, Colistin, Doripenem, Ertapenem, Imipenem, Linezolid, Meropenem, and Moxifloxacin (Assary 2011).
Part B contains 74 drugs that could only be sold at pharmacies to patients with two copies of a prescription from a RMP. These include Amoxicillin, Ampicillin, Cefaclor, Cefalexin, Cefdinir, Ciprofloxacin, Erythromycin, Gentamicin, Norfloxacin, Oxacillin, Pencillin, antibiotic eye drops, some drugs for tuberculosis, sleeping pills, paracetamol and cough syrups such as Benadryl (Assary 2011; Deshpande 2011; Times News Network 2011).
Some Ministry of Health officials and doctors have defended the new regulations, pointing out that only very specialized, expensive drugs will be limited to tertiary hospitals, and that it is important to restrict these antibiotics to stem the spread of antibiotic resistance (Deshpande 2011; Express News Service 2011). Indeed, in situations where diagnostic and antibiotic sensitivity tests are unavailable, it is unwise for patients to take expensive, strong drugs. These drugs should only be prescribed when it has been determined that the patient is resistant to milder, widely available antibiotics through diagnostic tests. If patients are wantonly prescribed newer antibiotics, such as those restricted to tertiary hospitals, this will lead to a decrease in their effectiveness when patients with resistant infections really need them.
However, several parts of this new regulation have caused widespread protest. The All India Organization of Chemists and Druggists (AIOCD) has pointed out that in many rural areas, RMPs are scarce or unavailable, making many drugs inaccessible to rural populations (Deshpande 2011). Others fear that new regulations will make life-saving drugs scarce, and lead to increased use of the black market (Indian Pharmacist Association and Pharmabiz 2011). To show their opposition, several pharmacists’ organizations staged a strike on August 1st (Express News Service 2011; Indian Pharmacist Association and Pharmabiz 2011; Times News Network 2011). However, many re-opened during the day due to the protests of customers and police (Express News Service 2011). After a meeting with the Health Minister, the strike was officially called off in Delhi and other locations, based on the feeling that there is still time to change the specifics of the new regulations before they are enacted (Ahuja 2011; Indo-Asian News Service 2011).
These controversial new regulations raise a number of interesting issues. Of course, pharmacists are only part of the picture. The new antibiotic policy contains measures targeting overprescribing of antibiotics as well, such as educational programs for physicians (Ministry of Health & Family Welfare 2011). Preventing doctors from primary and secondary level facilities from dispensing the newest antibiotics without the diagnostic tests to determine whether they are necessary could also go a long way towards preserving the effectiveness of new antibiotics, which would ideally only be used when absolutely necessary. However, these regulations may have been diluted by the inclusion of drugs other than antibiotics. I find it hard to believe that I will actually be unable to buy paracetamol (acetaminophen) and cough syrup once these new regulations are put in place. Just in case, I’m planning on stocking up.
------------------------------------
References:
Ahuja, S. (2011). Chemists to remain open on August 1. Hindustan Times. Gurgaon.
Assary, G. (2011). Losing battle against bacteria? Deccan Chronicle. Thiruvananthapuram.
Deshpande, D. (2011). Chemists super bugged by govt’s new policy. Pune Mirror. Pune.
Express News Service (2011). Chemists strike over new rules for drug sale, leave patients stranded. Indian Express. New Delhi.
Express News Service (2011). Chemists to down shutters on Aug 1 to protest antibiotics order. Indian Express.
Indian Pharmacist Association and Pharmabiz. (2011). "AICDF calls for pharmacy bandh in Delhi & Haryana against govt’s decision to include Schedule HX in D&C Rules." Retrieved July 29, 2011.
Indo-Asian News Service (2011). Chemists end strike after meeting Ghulam Nabi Azad. NDTV. New Delhi.
Ministry of Health & Family Welfare. (2011). "National Policy for Containment of Antimicrobial Resistance - India." from http://www.nicd.nic.in/ncdc_new/ab_policy.pdf.
Times News Network (2011). Druggists warn of stir over move to ban 90 OTC drugs. Times of India. Hyderabad.
Subscribe to:
Posts (Atom)